Noiman S - Search Results

1

Modeling the 3D structure of GPCRs from sequence.

Shacham S, Topf M, Avisar N, Glaser F, Marantz Y, Bar-Haim S, Noiman S, Naor Z, Becker OM. Shacham S, et al. Among authors: noiman s. Med Res Rev. 2001 Sep;21(5):472-83. doi: 10.1002/med.1019. Med Res Rev. 2001. PMID: 11579443 Review.

2

Modeling the 3D structure of GPCRs: advances and application to drug discovery.

Becker OM, Shacham S, Marantz Y, Noiman S. Becker OM, et al. Among authors: noiman s. Curr Opin Drug Discov Devel. 2003 May;6(3):353-61. Curr Opin Drug Discov Devel. 2003. PMID: 12833668 Review.

3

PREDICT modeling and in-silico screening for G-protein coupled receptors.

Shacham S, Marantz Y, Bar-Haim S, Kalid O, Warshaviak D, Avisar N, Inbal B, Heifetz A, Fichman M, Topf M, Naor Z, Noiman S, Becker OM. Shacham S, et al. Among authors: noiman s. Proteins. 2004 Oct 1;57(1):51-86. doi: 10.1002/prot.20195. Proteins. 2004. PMID: 15326594

4

G protein-coupled receptors: in silico drug discovery in 3D.

Becker OM, Marantz Y, Shacham S, Inbal B, Heifetz A, Kalid O, Bar-Haim S, Warshaviak D, Fichman M, Noiman S. Becker OM, et al. Among authors: noiman s. Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11304-9. doi: 10.1073/pnas.0401862101. Epub 2004 Jul 26. Proc Natl Acad Sci U S A. 2004. PMID: 15277683 Free PMC article.

5

An integrated in silico 3D model-driven discovery of a novel, potent, and selective amidosulfonamide 5-HT1A agonist (PRX-00023) for the treatment of anxiety and depression.

Becker OM, Dhanoa DS, Marantz Y, Chen D, Shacham S, Cheruku S, Heifetz A, Mohanty P, Fichman M, Sharadendu A, Nudelman R, Kauffman M, Noiman S. Becker OM, et al. Among authors: noiman s. J Med Chem. 2006 Jun 1;49(11):3116-35. doi: 10.1021/jm0508641. J Med Chem. 2006. PMID: 16722631

6

VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux.

Mohler EG, Shacham S, Noiman S, Lezoualc'h F, Robert S, Gastineau M, Rutkowski J, Marantz Y, Dumuis A, Bockaert J, Gold PE, Ragozzino ME. Mohler EG, et al. Among authors: noiman s. Neuropharmacology. 2007 Sep;53(4):563-73. doi: 10.1016/j.neuropharm.2007.06.016. Epub 2007 Jun 30. Neuropharmacology. 2007. PMID: 17692343

7

Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interaction.

Musafia B, Oren-Banaroya R, Noiman S. Musafia B, et al. Among authors: noiman s. PLoS One. 2014 May 20;9(5):e97696. doi: 10.1371/journal.pone.0097696. eCollection 2014. PLoS One. 2014. PMID: 24846127 Free PMC article.

8

Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation.

Augarten A, Kerem BS, Yahav Y, Noiman S, Rivlin Y, Tal A, Blau H, Ben-Tur L, Szeinberg A, Kerem E, et al. Augarten A, et al. Among authors: noiman s. Lancet. 1993 Jul 3;342(8862):25-6. doi: 10.1016/0140-6736(93)91885-p. Lancet. 1993. PMID: 8100293

9

Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.

Rosin-Arbesfeld R, Rivlin M, Noiman S, Mashiah P, Yaniv A, Miki T, Tronick SR, Gazit A. Rosin-Arbesfeld R, et al. Among authors: noiman s. J Virol. 1993 Sep;67(9):5640-6. doi: 10.1128/JVI.67.9.5640-5646.1993. J Virol. 1993. PMID: 8394464 Free PMC article.

10

The Tat protein of equine infectious anemia virus is encoded by at least three types of transcripts.

Noiman S, Yaniv A, Tsach T, Miki T, Tronick SR, Gazit A. Noiman S, et al. Virology. 1991 Oct;184(2):521-30. doi: 10.1016/0042-6822(91)90422-8. Virology. 1991. PMID: 1653485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters